In 2020, Mom was dealing with the covid pandemic as well as cancer. After her chemotherapy treatment ended, she started on a new drug, called niraparib, to try and prevent a recurrence. She would end up back in the emergency room, but this time, it wasn’t covid, or cancer. 

And, I talked to Dr Tracy Brooks for a deep dive on PARB inhibitors, a relatively new class of drugs used in cancer treatment. 

This episode features:

Dr Tracy Brooks, Binghamton University, New York.

For more background on this episode, head to overlookedpod.com, where you can also get in touch with us.

New to the show? Start with episode 1, ‘Fluid Puppy’

How you can support the show: 

• Leave a review on Apple Podcasts
• Hit the subscribe button
• Send this episode to someone who would also find it a meaningful listen

New to Overlooked? Welcome. 

Overlooked was launched in 2023 to tell the story of ovarian cancer through one woman's story. In 2024 the show started to cover other overlooked topics in women's health - and there are many. Overlooked is hosted by Golda Arthur, an audio journalist and producer. 

Our newsletter is written by Golda, and has the backstory to the episodes, and other women's health stories of interest. You can get on the mailing list here https://overlookedpodcast.kit.com/e4b85028b6

LEARN MORE on our website https://overlookedpod.com/ and if you want to support Overlooked to keep doing this work, you can make a contribution here https://overlookedpodcast.kit.com/products/make-a-one-time-donation-to-overlooked.

SEND US AN EMAIL [email protected]

FOLLOW US:

Instagram https://www.instagram.com/overlookedpod/

LinkedIn https://www.linkedin.com/company/105541285/admin/dashboard/

DISCLAIMER What you hear and read on ‘Overlooked’ is for general information purposes only and represents the opinions of the host and guests. The content on the podcast and website should not be taken as medical advice. Every person’s body is unique, so please consult your healthcare professional for any medical questions that may arise.